SEC Form 5/A · accession 0001078782-17-000274
AXIM BIOTECHNOLOGIES, INC. · AXIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 5/A). It replaces an earlier filing for the same period.
Reporting owner
Medical Marijuana Inc
10% Owner
Period of report
Dec 31, 2016
Accepted (ET)
Feb 28, 2017 · 7:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001514946
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 2, 2016 | A | 7,200,000 | $0.00 | A | 22,669,125 | D | |
| Preferred StockF2 | Nov 21, 2016 | A | 500,000 | $0.00 | A | 500,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reporting person is the owner of MJNA Investment Holdings, LLC which holds 17,969,125 shares of common stock.
- F2Reporting person holds 500,000 shares of Series C Preferred Stock.